Cargando…

A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab

Detalles Bibliográficos
Autores principales:	Bernardini, Nicoletta, Skroza, Nevena, Marraffa, Federica, Prevete, Elisabeth, Mambrin, Alessandra, Proietti, Ilaria, Tolino, Ersilia, Caviglia, Martina, Di Guardo, Antonio, Rossi, Giovanni, Volpe, Salvatore, Bersani, Giuseppe, Potenza, Concetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539526/ https://www.ncbi.nlm.nih.gov/pubmed/35460156 http://dx.doi.org/10.1111/dth.15533

Ejemplares similares

Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

Safety and Impact of Anti-COVID-19 Vaccines in Psoriatic Patients Treated with Biologics: A Real Life Experience
por: Skroza, Nevena, et al.
Publicado: (2021)

A Case of Psoriatic Disease and Hidradenitis Suppurativa in a Child with Chromosome 17q21.31 Microduplication Syndrome
por: Tolino, Ersilia, et al.
Publicado: (2023)

Aesthetic Treatments in Cancer Patients
por: Proietti, Ilaria, et al.
Publicado: (2021)

Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
por: Skroza, Nevena, et al.
Publicado: (2021)

Long-Term Maintained Response to Selective Internal Radiation Therapy in an Oligometastatic Uveal Melanoma Patient Treated with Concomitant Anti-PD-1 Therapy
por: Proietti, Ilaria, et al.
Publicado: (2021)

Management of psoriatic patients in biologic treatment associated with infectious comorbidities
por: Nicoletta, Bernardini, et al.
Publicado: (2020)

A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma
por: Potenza, Concetta, et al.
Publicado: (2018)

Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
por: Proietti, Ilaria, et al.
Publicado: (2023)

Correlations between Psoriasis and Inflammatory Bowel Diseases
por: Skroza, Nevena, et al.
Publicado: (2013)

Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
por: Skroza, Nevena, et al.
Publicado: (2017)

The Role of the Western Diet on Atopic Dermatitis: Our Experience and Review of the Current Literature
por: Ilaria, Proietti, et al.
Publicado: (2023)

IL‐17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art
por: Bernardini, Nicoletta, et al.
Publicado: (2019)

Do Diet and Lifestyles Play a Role in the Pathogenesis of NMSCs?
por: Skroza, Nevena, et al.
Publicado: (2020)

Evaluation of Cardiovascular Risk in Hidradenitis Suppurativa Patients Using Heart Rate Variability (HRV) Analysis
por: Skroza, Nevena, et al.
Publicado: (2020)

Adverse skin reactions to personal protective equipment during COVID‐19 pandemic in Italian health care workers
por: Proietti, Ilaria, et al.
Publicado: (2022)

Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study
por: Potenza, Concetta, et al.
Publicado: (2016)

Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
por: Proietti, Ilaria, et al.
Publicado: (2020)

BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions
por: Proietti, Ilaria, et al.
Publicado: (2020)

Eruptive Blue Nevi of the Scalp in a Patient with Mayer–Rokitansky–Küster–Hauser Syndrome during Isotretinoin Therapy
por: Skroza, Nevena, et al.
Publicado: (2019)

How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy
por: Bernardini, N., et al.
Publicado: (2021)

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
por: Skroza, Nevena, et al.
Publicado: (2018)

Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature
por: Proietti, Ilaria, et al.
Publicado: (2023)

A Case Report of Monkeypox in an Adult Patient from Italy: Clinical and Dermoscopic Manifestations, Diagnosis and Management
por: Proietti, Ilaria, et al.
Publicado: (2022)

Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
por: Gisondi, Paolo, et al.
Publicado: (2014)

Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab
por: Herrero-Moyano, María, et al.
Publicado: (2018)

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis
por: Elewski, Boni E., et al.
Publicado: (2021)

Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan
por: Fujita, Hideki, et al.
Publicado: (2020)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016)

Secukinumab: A Review in Psoriatic Arthritis
por: Blair, Hannah A.
Publicado: (2021)

Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
por: Fargnoli, Maria Concetta
Publicado: (2019)

Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
por: Cai, Lin, et al.
Publicado: (2021)

Secukinumab in Generalized Pustular Psoriasis
por: Madanagobalane, Shraddha
Publicado: (2018)

A Review of the Use of Secukinumab for Psoriatic Arthritis
por: Patel, Nupur U., et al.
Publicado: (2017)

Correction to: Secukinumab: A Review in Psoriatic Arthritis
por: Blair, Hannah A.
Publicado: (2021)

Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain
por: Schweikert, Bernd, et al.
Publicado: (2020)

Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report
por: Lu, Jiajing, et al.
Publicado: (2020)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
por: Alonso, Sara, et al.
Publicado: (2021)

Changes in metabolic parameters in psoriatic patients treated with secukinumab
por: Wang, Hsuan Ning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oks2tj4cn195cdkgsl83ukuilo